Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >Novo Nordisk plunge wipes $50 billion off obesity drug giant
    Finance

    Novo Nordisk Plunge Wipes $50 Billion Off Obesity Drug Giant

    Published by Global Banking & Finance Review®

    Posted on February 4, 2026

    2 min read

    Last updated: February 4, 2026

    Add as preferred source on Google
    Novo Nordisk plunge wipes $50 billion off obesity drug giant - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:market capitalisationfinancial crisiscorporate profitsfinancial management

    Quick Summary

    Novo Nordisk shares fell 16%, losing $50 billion in market value due to a forecasted sales and profit decline in 2026, marking the first revenue drop since 2017.

    Novo Nordisk Shares Plunge, Losing $50 Billion in Market Value

    Impact of Sales Forecast on Novo Nordisk

    Feb 4 (Reuters) - Novo Nordisk shares tumbled 16% on Wednesday, wiping off around $50 billion from the Wegovy maker's market capitalization after it warned on Tuesday its sales and profits would fall in 2026.

    Novo Nordisk, which was worth more than $600 billion in 2024, said it expected both its sales and operating profit to fall between 5% and 13% this year, affected by lower drug prices in the United States.

    That would be the company's first revenue decline since 2017, according to LSEG data.

    Investor Reactions

    "After a year in which Novo Nordisk disappointed investors several times with downward adjustments, Novo has delivered yet another blow to investors," analysts from Jyske Bank said in a note to clients.

    Market Capitalization Changes

    Novo Nordisk's Copenhagen-listed shares were set for their biggest one-day drop since July, if the losses hold through the day, having wiped off all their gains from the beginning of the year.

    Wednesday's share drop wiped more than 40 billion euros off the company's market capitalisation, which was at 216 billion euros ($255 billion) at Tuesday's close.

    ($1 = 0.8460 euros)

    (Reporting by Boleslaw Lasocki, additional reporting by Josehpine Mason and Canan Sevgili)

    Table of Contents

    • Impact of Sales Forecast on Novo Nordisk
    • Investor Reactions
    • Market Capitalization Changes

    Key Takeaways

    • •Novo Nordisk shares dropped 16%, losing $50 billion in value.
    • •The company forecasts a 5-13% decline in sales and profits for 2026.
    • •This marks the first revenue decline since 2017.
    • •Investor confidence shaken by repeated downward adjustments.
    • •Copenhagen-listed shares experience significant drop.

    Frequently Asked Questions about Novo Nordisk plunge wipes $50 billion off obesity drug giant

    1What is market capitalisation?

    Market capitalisation is the total market value of a company's outstanding shares of stock, calculated by multiplying the share price by the total number of shares.

    2What are corporate profits?

    Corporate profits refer to the earnings of a company after all expenses, taxes, and costs have been deducted from total revenue.

    3
    What is investor reaction?

    Investor reaction refers to the response of investors to news or events affecting a company, which can influence stock prices and market trends.

    4What is a financial crisis?

    A financial crisis is a situation in which the value of financial institutions or assets drops significantly, often leading to widespread economic instability.

    More from Finance

    Explore more articles in the Finance category

    Image for Factbox-Highlights of EU-Australia trade agreement
    Factbox-Highlights of EU-Australia Trade Agreement
    Image for Two pilots killed in New York runway collision, Trump deploys ICE to strained US airports
    Two Pilots Killed in New York Runway Collision, Trump Deploys Ice to Strained US Airports
    Image for Dollar nurses losses as markets weigh Trump delay in Iran strikes
    Dollar Nurses Losses as Markets Weigh Trump Delay in Iran Strikes
    Image for Oil rises as markets assess supply risks after Iran denies US talks
    Oil Rises as Markets Assess Supply Risks After Iran Denies US Talks
    Image for Shares rally, oil retreats as Trump extends Iran ultimatum
    Shares Rally, Oil Retreats as Trump Extends Iran Ultimatum
    Image for US crude oil futures rise over $1 in early Asia trade
    US Crude Oil Futures Rise Over $1 in Early Asia Trade
    Image for Union says BP lockout at Indiana oil refinery was unfair, urges return to talks
    Union Says Bp Lockout at Indiana Oil Refinery Was Unfair, Urges Return to Talks
    Image for Shell concerned Iran war will impact long-term confidence in LNG supply
    Shell Concerned Iran War Will Impact Long-Term Confidence in Lng Supply
    Image for Exor to generate $2.3 billion from stake sales in Iveco, GEDI, Lifenet and NUO
    Exor to Generate $2.3 Billion From Stake Sales in Iveco, Gedi, Lifenet and Nuo
    Image for Trading Day: TACO back on the menu
    Trading Day: Taco Back on the Menu
    Image for US, Ukraine to meet on reconstruction fund, eye first investment project
    Us, Ukraine to Meet on Reconstruction Fund, Eye First Investment Project
    Image for Australia, EU push to seal trade deal as Von der Leyen visits
    Australia, EU Push to Seal Trade Deal as Von Der Leyen Visits
    View All Finance Posts
    Previous Finance PostAustria's Omv Tops Profit View, Says Borouge to Be Listed in Vienna in 2027
    Next Finance PostLive Nation to Acquire Italy's ForumNet, Valued at $106 Million